- 专利标题: Method for uses of proinsulin transferrin fusion proteins as prodrugs
-
申请号: US13476812申请日: 2012-05-21
-
公开(公告)号: US10513563B2公开(公告)日: 2019-12-24
- 发明人: Wei-Chiang Shen , Yan Wang , Jennica Krankel
- 申请人: Wei-Chiang Shen , Yan Wang , Jennica Krankel
- 申请人地址: US CA Los Angeles
- 专利权人: University of Southern California
- 当前专利权人: University of Southern California
- 当前专利权人地址: US CA Los Angeles
- 代理机构: DLA Piper LLP (US)
- 主分类号: C07K19/00
- IPC分类号: C07K19/00 ; A61K38/28 ; C07K14/62 ; C07K14/79 ; A61K47/64
摘要:
The present invention provides compositions useful as prodrugs and methods for making the same. The compositions include a fusion protein having a first delivery domain and a second protein precursor domain linked together via a linker sequence. The delivery domain is a protein capable of facilitating entry to a target cells via the endocytotic pathway, such as transferrin. The protein precursor is a prohormone or a profactor, such as proinsulin. Methods of this invention include the steps of selecting a protein suitable as the delivery domain, constructing a vector to encode the fusion protein, and expressing the fusion protein in a suitable expression host. Also disclosed is a method for targeted-delivery of prodrugs to livers and a method of reducing hepatic glucose production.
公开/授权文献
- US20130130967A1 Method for Uses of Protein Precursors as Prodrugs 公开/授权日:2013-05-23
信息查询